Icon recently announced that its PMG Research has formed a clinical research partnership agreement with DuPage Medical Group. Starting this month, PMG Research will serve as the research infrastructure at DuPage Medical. The partnership will help expand PMG Research’s network to help Icon have more access and engagement with investigator sites and patients to reduce overall
Patient enrollment could be a top challenge in declining R&D efficiency
May 10, 2018 By Leave a Comment
Patient enrollment is one of the biggest challenges of declining research and development efficiency, according to a new survey from Icon and Pharma Intelligence. Pharmaceutical industry executives discussed the challenges facing the pharmaceutical industry outlined in the survey in a recent roundtable. The discussion was designed to help industry experts figure out the potential for
RxFunction announces clinical trial for Walkasins wearable sensory prosthetic
May 10, 2018 By Leave a Comment
RxFunction (Eden Prairie, Minn.) recently announced that it plans to conduct its first long-term clinical trial of its wearable sensory prosthetic Walkasins in the Walk2Wellness study. The Walk2Wellness clinical trial plans to evaluate how well Walkasins work on 100 patients from different locations across the U.S. The patients will all have sensory peripheral neuropathy with gait
Icon and Intel forge partnership for pharmaceutical analytics platform for clinical trials
April 19, 2018 By Leave a Comment
Icon and Intel have struck an deal that allows Icon to offer the Intel Pharma Analytics Platform in clinical trials. The financial details of the deal were not disclosed. The Intel platform is an edge-to-cloud artificial intelligence platform that allows clinical data to be remotely monitored while it continuously captures data for study participants who
Medpace stock down 18% after CEO talks of ‘permanent or increasing margin headwind’
February 27, 2018 By Leave a Comment
The stock of clinical contract research organization Medpace (Nasdaq: MEDP) took a hit today after the company’s CEO Dr. August Troendle told analysts that the company is facing a “relatively permanent or increasing margin headwind in the next few years.” Medpace’s stock was down $7.02 per share, or nearly 18%, to $32.02 by the close of trading.
Webinar: How to make sense of safety oversight in clinical research — DSMBs, CECs and Medical Monitors
February 20, 2018 By Leave a Comment
This webinar was presented live on Thursday, March 22, 2018. Click below to watch on demand. This webinar will provide clinical research professionals with an understanding of safety oversight for clinical studies, including regulatory requirements and best practices. The presentation will include a discussion of the FDA’s Guidance on the Establishment and Operation
Antidote looks to leverage AI, travel e-commerce tech to improve clinical trial enrollment
January 31, 2018 By Leave a Comment
Clinical trial artificial intelligence company Antidote is looking to improve access to and enrollment in clinical trials using technology from the e-commerce world, according to a Wired report. Former travel and airline fare aggregator Kayak VP Pablo Graiver is heading the operation, which streamlines access to clinical trials for patients seeking them out. Read
Report slams European Union’s high-risk medical device approvals rate
January 2, 2018 By 1 Comment
A health economics and outcomes research group has concluded that the assessment for high-risk medical devices in the European Union is of low quality and needs improvement. The report appears in the December 2017 issue of Value in Health by ISPOR. The authors looked at 1,376 health technology assessment (HTA) reports filed between 2010 and 2015.
How to work with a preclinical contract research organization
November 14, 2017 By Leave a Comment
When outsourcing medical device laboratory testing, knowing what the regulatory and business requirements are up front is critical to the success of your testing program. Amy A. Schade, Felice Randi LaMadeleine and J. Heléne Andersson, Toxikon Requests such as unusual application of technical or regulatory guidelines, shortened timelines, nonstandard study designs and custom reports are
Webinar: Could this new software help you with clinical trials?
October 30, 2017 By Leave a Comment
This webinar was presented live on Tuesday, Nov. 28, 2017. Click below to watch on demand. Staicy is a next-generation health and research management platform which provides full transparency of your clinical data. Learn about integrating seamlessly your internal and external clinical applications and utilizing staicy’s proprietary functionality to uniquely select a geographical
The top 10 medical disruptors of 2018
October 27, 2017 By 1 Comment
Each year the Cleveland Clinic determines what the top 10 disruptors in healthcare will be for the following year. The criteria to be considered a disruptor is that it has to be so innovative that it could change healthcare in a significant way in the next year. Approximately 150 to 200 Cleveland Clinic physicians from
Medtech stories we missed this week: Oct. 20, 2017
October 20, 2017 By Leave a Comment
From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD inks Chile distribution deal InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime
Medtech stories we missed this week: Oct. 6, 2017
October 6, 2017 By Leave a Comment
From Intellijoint’s CE Mark to Patrona Medical and Kopis’ new partnership, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Intellijoint CE Mark for flagship hip navigation Intellijoint surgical announced in an Oct. 4 press release that it has received CE Mark for its Intellijoint HIP System in
How to design a successful embolic protection devices clinical trial
September 20, 2017 By Leave a Comment
Embolic protection devices could reduce risks of interventional cardiac procedures such as TAVR, but their efficacy is hard to prove. David Novotny, Novella Clinical The embolic protection device (EPD) market is expected to grow into a billion-dollar industry if the device becomes the standard safety protocol for transcatheter aortic valve replacement (TAVR) and other interventional
Medtech stories we missed this week: Sept. 15, 2017
September 15, 2017 By Leave a Comment
From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention. 1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to
